» Articles » PMID: 2908728

Clinical Significance of Thyrotrophin Binding Inhibitor Immunoglobulins in Patients with Graves' Disease and Various Types of Thyroiditis

Overview
Specialty General Medicine
Date 1987 Jan 1
PMID 2908728
Authors
Affiliations
Soon will be listed here.
References
1.
Parker R, BEIERWALTES W . Thyroid antibodies during pregnancy and in the newborn. J Clin Endocrinol Metab. 1961; 21:792-8. DOI: 10.1210/jcem-21-7-792. View

2.
Inada M, Nishikawa M, Oishi M, Kurata S, Imura H . Transient thyrotoxicosis associated with painless thyroiditis and low radioactive iodine uptake. Arch Intern Med. 1979; 139(5):597-9. View

3.
Sugenoya A, Kidd A, Row V, Volpe R . Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders. J Clin Endocrinol Metab. 1979; 48(3):398-402. DOI: 10.1210/jcem-48-3-398. View

4.
Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y . Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1978; 46(5):734-9. DOI: 10.1210/jcem-46-5-734. View

5.
Smith B, Hall R . Thyroid-stimulating immunoglobulins in Graves' disease. Lancet. 1974; 2(7878):427-31. DOI: 10.1016/s0140-6736(74)91815-7. View